Have you recently been diagnosed with localized prostate cancer?

Has your prostate cancer recurred following external beam or radiation seed therapy?

If so, be aware that High Intensity Focused Ultrasound (HIFU) appears to have a clear indication in the definitive therapy for both virgin prostate cancer and radiation failure.

This outpatient procedure is performed harmlessly through the rectal wall, without blood loss, and requiring no downtime on the part of the patient. Once a patient's prostate is “mapped” (precisely measured in every direction), the treatment can begin.

The same probe that continually looks at the gland also provides the therapy. A curved disc focuses high frequency sound waves directly into the prostate creating a defined area of intense heat for about 3 seconds. Once that piece of prostate (the size of a grain of rice) is destroyed, the program moves onto another one, then yet another one, and keeps going until all living tissue in the entire prostate has been eliminated.

High intensity focused ultrasound provides such an exact distribution of heat, that even prostate tissue 1 mm (1/25 inch) from a nerve can be treated without damaging the nerve. The implication for this degree of surgical accuracy is obvious.

HIFU is in clinical trials to seek FDA approval in the United States. However, the HIFU procedure is already available internationally in Canada, Mexico and the Caribbean.  For more information about clinical trials please visit www.USHIFU.com.

Please visit www.InternationalHIFU.com for most of the available clinical information or make an appointment with my office at (352) 383-3773 in order to discuss your possible candidacy for HIFU. Be aware that non-FDA approved procedures are rarely reimbursed by Medicare.

Sonablate ® HIFU is only approved for investigational use in the United States and is currently in FDA-approved Phase III clinical studies. Sonablate ® HIFU is available in other countries worldwide for localized prostate disease.